December 26, 2014 7:37 AM ET

Pharmaceuticals

Company Overview of KAI Pharmaceuticals, Inc.

Company Overview

KAI Pharmaceuticals, Inc. provides biopharmaceutical drug discovery and development services. The company develops KAI-4169, a calcium-sensing receptor agonist, as an intravenous bolus product for the treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD) in patients with end-stage renal disease receiving hemodialysis. Its KAI-4169 is also being developed as a transdermal patch product for daily administration in the treatment of stage 3 and 4 CKD-MBD pre-dialysis patients; ESRD (Stage 5 kidney disease) patients receiving peritoneal dialysis; renal transplant patients with CKD-MBD; and primary hyperparathyroid patients who are ineligible or do not elect to undergo parathyroi...

270 Littlefield Avenue

South San Francisco, CA 94080-6924

United States

Founded in 2002

Phone:

650-244-1100

Fax:

650-244-1199

Key Executives for KAI Pharmaceuticals, Inc.

Co-Founder and Associate Director of Cardiovascular Pharmacology
Chief Medical Officer and Senior Vice President of Development
Vice President of Intellectual Property
Age: 53
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Myriad Genetic Laboratories, Inc. United States
Celsis Laboratory Group, Inc. United States
Thetis Pharmaceuticals LLC United States
Pharmaceutical Associates, Inc. United States
Sunrise Pharmaceutical, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KAI Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.